Nantahala Capital Management, LLC
Position in EW — Edwards Lifesciences Corp
CIK 1472322
New Canaan, CT
Position in EW
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Derivatives in EW
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$64,064,000
PutShares
800,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Mar 31, 2026Nantahala Capital Management, LLC holds $206,036,807 across 12 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BVS |
Bioventus Inc.
|
6,122,403 | $55,897,539 | |
| 2 | ESTA |
Establishment Labs Holdings Inc.
|
832,956 | $47,295,241 | |
| 3 | XTNT |
Xtant Medical Holdings, Inc.
|
68,394,000 | $38,300,640 | |
| 4 | ITGR |
Integer Holdings Corp
|
172,000 | $15,136,000 | |
| 5 | APYX |
Apyx Medical Corp
|
3,440,304 | $12,694,721 | |
| 6 | TLSI |
TriSalus Life Sciences, Inc.
|
2,070,827 | $8,283,308 | |
| 7 | VMD |
Viemed Healthcare, Inc.
|
883,783 | $8,139,641 | |
| 8 | NSPR |
InspireMD, Inc.
|
3,376,484 | $5,503,668 |
All Filings in EW
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $64,064,000 | 800,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $153,450,000 | 1,800,000 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $139,986,000 | 1,800,000 | Put | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||